Ambulatory glucose profile (AGP) is a single-page, standardized report for interpreting a patient's daily glucose and insulin patterns. AGP provides both graphic and quantitative characterizations of daily glucose patterns. First developed by Drs. Roger Mazze and David Rodbard, with colleagues at the Albert Einstein College of Medicine in 1987, AGP was initially used for the representation of episodic self-monitored blood glucose (SMBG). The first version included a glucose median and inter-quartile ranges graphed as a 24-hour day. Dr. Mazze brought the original AGP to the International Diabetes Center (IDC) in the late 1980s. Since then, IDC has built the AGP into the internationally recognized standard for glucose pattern reporting.
CaptῡrAGP is a registered trademark of the International Diabetes Center. The AGP, as it is known in the diabetes community, now includes several additional sections: glucose statistics, glucose profile graph, and either daily glucose pattern calendar images or insulin dosage graphs.
Early developments
Near the end of the 1970s two revolutions were taking place that were destined to change the course of diabetes care: the move from urine testing to self-monitored blood glucose (SMBG); and a new measurement for glycation of hemoglobin. The former led to the widespread use of reflectance meters and accompanying glucose oxidase strips to accurately and instantly measure current glucose levels and the latter to an integrated measure of overall glycemic control. The Albert Einstein College of Medicine proved pivotal in both instances. The AGP was first proposed at the Diabetes Research and Training Center (DRTC) and developed by Mazze and associates in the first laboratory to extensively utilize computer technologies in diabetes care.
In the 1970s US Congress was convinced to establish diabetes as a major health concern and to fund research through the National Institutes of Health (NIH). The DRTC program was designed to lead this effort by promoting innovate, multi-disciplinary, translational research focusing on improving diabetes care while still seeking to cure type 1 diabetes and prevent type 2 diabetes. Consequently, the DRTC was very excited about the use of SMBG in clinical decision-making. However, almost right from its introduction a potential problem was identified. Patients were expected to self-test by placing a sample of capillary blood on a strip and inserting the strip into a reflectance meter. The results of the tests (glucose values) were to be recorded in a logbook and brought to the physician.
At Einstein, an NIH funded project was undertaken to use SMBG data to devise an algorithm that would determine how much insulin was required to alter blood glucose levels in type 1 diabetes. It quickly became clear that 96 patients testing 4 times a day would produce an enormous amount of data and that these data would somehow have to be copied and recorded by hand on spreadsheets. By happenstance, working with systems analysts, a memory chip was added to the reflectance meter and software was developed to capture the patient data. Using these modified meters in the study patients it was discovered that the data recorded in their logbooks were subject to three errors: over-reporting, under-reporting and imprecision. This resulted in 75% of the research patients providing erroneous glucose data thus thwarting efforts to find an algorithm. Following publication of these results, other investigators confirmed the findings suggesting that patient self-reported data were subject to fabrication and unless independently verified might prove dangerous in terms of clinical decision-making.
Based on this mounting evidence, reflectance meter manufacturers quickly converted to memory-based meters with computer printouts. However, despite this revolution, the use of SMBG and electronic reports, although fully supported by the American Diabetes Association, never reached its potential due in part to the popularization of glycated hemoglobin (HbA1c) as the primary basis for clinical decision-making.
Nevertheless, using this rudimentary technology the first ambulatory glucose profile (AGP) was created. All data, regardless of date, was plotted by time and subjected to a smoothing algorithm to represent glucose exposure (median) and variability (inter-quartile range). Later the 10th and 90th percentile curves were added to represent outliers. The earliest AGPs characterized daytime glucose patterns as overnight SMBG was sparse.